Frederick Lewis Altice MD, MA

Professor of Medicine (Infectious Diseases) and of Epidemiology (Microbial Diseases); Director, Clinical and Community Research; Director, HIV in Prisons Program; Director, Community Health Care Van; Icon Professor of Medicine, University of Malaya-Centre of Excellence for Research in AIDS (CERiA); Professor of Epidemiology and Public Health, Division of Epidemiology of Microbial Diseases

Biographical Info

Frederick L. Altice is a professor of Medicine, Epidemiology and Public Health and is a clinician, clinical epidemiologist, interventionist and researcher at Yale University School of Medicine and School of Public Health. Dr. Altice’s primary research project focuses on the interface between infectious diseases and substance use disorders and he has a special interest in Global Health. He also has a number of projects working in the criminal justice system, including transitional programs addressing infectious diseases, medication-assisted therapies (methadone, buprenorphine, extended release naltrexone), mental illness and social instability. Specific topics include alcohol and opioid use disorders on HIV treatment outcomes, HIV and substance abuse treatment, interface with the criminal justice system, and pharmacokinetic drug interactions between treatment for substance use disorders and antiretroviral and tuberculosis therapy. His research has focused on development of and evaluation of adherence interventions to antiretroviral therapy. Additionally, his research, using health services research techniques and implementation science, seeks to understand integration of methadone, buprenorphine and extended released naltrexone and its role in primary and secondary HIV prevention, including linkage to and retention in care. His work has a global health focus with funded research projects internationally in Malaysia, Ukraine, Russia, Central Asia, Peru, Indonesia and Argentina. He has participated in projects through the National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse, Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Agency and the Center for Substance Abuse Treatment. He is currently also collaborating on projects with the WHO, UNAIDS, USAID, PEPFAR and UNODC. Current internationally funded projects are being conducted in Malaysia, Ukraine, Russia and Peru.

International Activity

Studies of Alcohol and Drug Use Among MSM in Peru
Lima, Peru (2011 - 2016)
Biobehavioral Surveys, RCTs of XR-NTX among HIV+ MSM with alcohol use disorders and RCTs of early vs late initiation of ART among newly seroconverted MSM.
HIV, Opioid, Substance abuse, Malaysia
Malaysia (2010)
Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia
Infectious Diseases and Addiction
Kuala Lumpur, Malaysia (2005)
Funded Research Activities with Centre of Excellence in Research on AIDS (CERiA)
HIV/AIDS, Tuberculosis and Addiction
Ukraine (2005)
Technical Assistance and Research, Developed integrated health care delivery system, Rolled out buprenorphine and methadone

Education & Training

M.D.: Emory University (1986)
Resident: Yale University School of Medicine, Infectious Diseases
Fellow: Yale University School of Medicine, Infectious Diseases
Board Certification: Internal Medicine, Board Certified (1989)

Honors & Recognition

National Hope is a Vaccine" Award Recipient
GAIA, Global Alliance to Immunize against AIDS (2008)
Appointed as Icon Professor of Medicine, Centre for Excellence in Research in AIDS (CERiA) at University of Malaya
Infectious Diseases Unit, Department of Medicine, Faculty of Medicine, University of Malaya (2009)
Board of Permanent Officers
Yale University School of Medicine (2009)